Investment under the microscope: 2026 review and how capital will be allocated in 2027

Edition

Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.

Panel discussion

Investment under the microscope: 2026 review and how capital will be allocated in 2027

Looking back on 2026 investments in the early-stage landscape, experts will pause and analyse where capital went and what it says about the evolution of the life sciences market. Investors will then discuss what decisions they foresee for the year ahead, and how founders and tech transfer teams can adapt to raise capital.

Scroll to Top
  • No products in the cart.